DK1497289T3 - Drug containing betamimetics and a new anticholinergic - Google Patents
Drug containing betamimetics and a new anticholinergicInfo
- Publication number
- DK1497289T3 DK1497289T3 DK03746158T DK03746158T DK1497289T3 DK 1497289 T3 DK1497289 T3 DK 1497289T3 DK 03746158 T DK03746158 T DK 03746158T DK 03746158 T DK03746158 T DK 03746158T DK 1497289 T3 DK1497289 T3 DK 1497289T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug containing
- betamimetics
- new anticholinergic
- anticholinergic
- containing betamimetics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The invention relates to novel medicament compositions based on long-acting beta2 agonists and salts of a novel anticholinesterase drug (I), to methods for the production of these compositions and their use in treating respiratory tract diseases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10216428 | 2002-04-12 | ||
DE10256317A DE10256317A1 (en) | 2002-04-12 | 2002-12-03 | Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt |
PCT/EP2003/003669 WO2003087097A1 (en) | 2002-04-12 | 2003-04-09 | Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1497289T3 true DK1497289T3 (en) | 2005-10-24 |
Family
ID=29251756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03746158T DK1497289T3 (en) | 2002-04-12 | 2003-04-09 | Drug containing betamimetics and a new anticholinergic |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1497289B1 (en) |
JP (1) | JP2005529111A (en) |
CN (1) | CN1646527A (en) |
AT (1) | ATE302774T1 (en) |
AU (1) | AU2003232201B2 (en) |
BR (1) | BR0309185A (en) |
CA (1) | CA2481468C (en) |
DK (1) | DK1497289T3 (en) |
ES (1) | ES2248767T3 (en) |
HR (1) | HRP20040944B1 (en) |
IL (1) | IL164291A (en) |
MX (1) | MXPA04009916A (en) |
NO (1) | NO20044107L (en) |
NZ (1) | NZ536337A (en) |
PL (1) | PL213489B1 (en) |
PT (1) | PT1497289E (en) |
RS (1) | RS50735B (en) |
UY (1) | UY27757A1 (en) |
WO (1) | WO2003087097A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20040950A1 (en) | 2003-02-14 | 2005-01-01 | Theravance Inc | BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS |
US7244728B2 (en) | 2004-03-17 | 2007-07-17 | Boehringer Ingelheim International Gmbh | Long acting betamimetics for the treatment of respiratory diseases |
EP1577306A1 (en) * | 2004-03-17 | 2005-09-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases |
US7745621B2 (en) | 2004-05-14 | 2010-06-29 | Boehringer Ingelheim International Gmbh | Long acting bronchodilators for the treatment of respiratory diseases |
AU2006218177B2 (en) | 2005-02-25 | 2012-04-12 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
JP2009504624A (en) | 2005-08-08 | 2009-02-05 | アージェンタ ディスカバリー リミテッド | Bicyclo [2.2.1] hept-7-ylamine derivatives and uses thereof |
GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
DE102005055963A1 (en) * | 2005-11-24 | 2007-07-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
DE102005055957A1 (en) * | 2005-11-24 | 2007-07-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
GB0602778D0 (en) | 2006-02-10 | 2006-03-22 | Glaxo Group Ltd | Novel compound |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
EP2432531B1 (en) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalation device and nebulizer |
WO2011064164A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2012130757A1 (en) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
PL2835146T3 (en) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizer |
US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP6559157B2 (en) | 2014-05-07 | 2019-08-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
AU2015257878B2 (en) | 2014-05-07 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
SG10201709354PA (en) | 2014-05-07 | 2018-01-30 | Boehringer Ingelheim Int | Nebulizer, Indicator Device And Container |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4108393A1 (en) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS |
DE10050995A1 (en) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
DE10050994A1 (en) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
-
2003
- 2003-04-09 CA CA2481468A patent/CA2481468C/en not_active Expired - Fee Related
- 2003-04-09 WO PCT/EP2003/003669 patent/WO2003087097A1/en active IP Right Grant
- 2003-04-09 MX MXPA04009916A patent/MXPA04009916A/en active IP Right Grant
- 2003-04-09 BR BR0309185-6A patent/BR0309185A/en not_active Expired - Fee Related
- 2003-04-09 AU AU2003232201A patent/AU2003232201B2/en not_active Ceased
- 2003-04-09 AT AT03746158T patent/ATE302774T1/en active
- 2003-04-09 PT PT03746158T patent/PT1497289E/en unknown
- 2003-04-09 JP JP2003584053A patent/JP2005529111A/en active Pending
- 2003-04-09 EP EP03746158A patent/EP1497289B1/en not_active Expired - Lifetime
- 2003-04-09 CN CNA038083302A patent/CN1646527A/en active Pending
- 2003-04-09 DK DK03746158T patent/DK1497289T3/en active
- 2003-04-09 ES ES03746158T patent/ES2248767T3/en not_active Expired - Lifetime
- 2003-04-09 NZ NZ536337A patent/NZ536337A/en not_active IP Right Cessation
- 2003-04-09 RS YUP-898/04A patent/RS50735B/en unknown
- 2003-04-09 PL PL372450A patent/PL213489B1/en not_active IP Right Cessation
- 2003-04-10 UY UY27757A patent/UY27757A1/en not_active Application Discontinuation
-
2004
- 2004-04-09 IL IL164291A patent/IL164291A/en not_active IP Right Cessation
- 2004-09-27 NO NO20044107A patent/NO20044107L/en not_active Application Discontinuation
- 2004-10-11 HR HR20040944 patent/HRP20040944B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1497289B1 (en) | 2005-08-24 |
JP2005529111A (en) | 2005-09-29 |
HRP20040944B1 (en) | 2012-12-31 |
CA2481468A1 (en) | 2003-10-23 |
BR0309185A (en) | 2005-02-15 |
RS50735B (en) | 2010-08-31 |
PL213489B1 (en) | 2013-03-29 |
IL164291A0 (en) | 2005-12-18 |
ATE302774T1 (en) | 2005-09-15 |
AU2003232201B2 (en) | 2009-06-11 |
CA2481468C (en) | 2011-02-01 |
MXPA04009916A (en) | 2005-05-03 |
PL372450A1 (en) | 2005-07-25 |
HRP20040944A2 (en) | 2005-04-30 |
CN1646527A (en) | 2005-07-27 |
AU2003232201A1 (en) | 2003-10-27 |
NZ536337A (en) | 2007-05-31 |
WO2003087097A1 (en) | 2003-10-23 |
RS89804A (en) | 2006-10-27 |
PT1497289E (en) | 2005-11-30 |
EP1497289A1 (en) | 2005-01-19 |
ES2248767T3 (en) | 2006-03-16 |
NO20044107L (en) | 2004-11-04 |
UY27757A1 (en) | 2003-11-28 |
IL164291A (en) | 2012-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1497289T3 (en) | Drug containing betamimetics and a new anticholinergic | |
RS20050361A (en) | Novel medicament for the treatment of chronic obstructive pulmonary diseases | |
YU35503A (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
IS8230A (en) | Substitute 2-aminotetraline for use in the treatment of depression | |
DE60315492D1 (en) | MEDICALLY USEFUL ARYLETHANOLAMINE COMPOUNDS | |
YU71901A (en) | NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS | |
MXPA03005340A (en) | Novel medicament compositions based on anticholinesterase drugs and on ciclesonides. | |
CY1106430T1 (en) | MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG | |
ATE479433T1 (en) | NEW LONG-ACTING BETA-2 AGONISTS AND THEIR USE AS MEDICINAL PRODUCTS | |
UA85707C2 (en) | Benzoxazines for treating respiratory tract diseases | |
WO2003087049A3 (en) | Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent | |
EA200600854A1 (en) | NEW TIOTROPY SALTS, METHOD OF THEIR PRODUCTION, AND ALSO CONTAINING THEIR MEDICINAL COMPOSITIONS | |
RS89904A (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
BR0307703A (en) | Drug compositions based on anticholinergic agents and egfr kinase inhibitors | |
UY26990A1 (en) | NEW DRUG COMPOSITIONS | |
MXPA03008406A (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists. | |
ECSP045357A (en) | MEDICINAL CONTAINING BETAMIMETICS AND A NEW ANTI-POLERIGEN | |
DE502007006951D1 (en) | MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES | |
MXPA03005585A (en) | Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists. | |
DE50309096D1 (en) | TIOTROPHIC MEDICINAL COMBINATION FOR INHALATION | |
MXPA04002400A (en) | Salicylic acid salts, methods for the production and use thereof as medicaments. |